Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd held its 15th Annual General Meeting on 26th September 2025 from 03:00 PM to 03:30 PM at its registered office in Kolkata. Shareholders approved five resolutions, including adoption of audited financial statements for FY ended 31st March 2025 and re-appointment of Mr. Aman Patel (DIN: 08483544) as a director retiring by rotation. The Statutory Auditor was also re-appointed with remuneration to be fixed. Two special resolutions were passed: one to enhance the company's borrowing limits under Section 180(1)(c) of the Companies Act, 2013, and another to allow investments, loans, guarantees and security beyond the limits specified under Section 186 of the Companies Act, 2013. The voting results will be filed separately under Regulation 44(3).
The re-appointments and financial approvals are routine, but the special resolutions to raise borrowing limits and extend investment/loan powers under Section 186 give the company greater flexibility for debt and capital deployment, which could affect future leverage and risk profile.